EU Pharma Leader Urges European Nasdaq to Accelerate Biotech Innovation
The head of the EUs pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, modelled after the US Nasdaq, to help retain biotech innovation and investment within the region. ADVERTISEMENT